Long-term quality of life after resection of retroperitoneal soft tissue sarcoma

Eur J Surg Oncol. 2023 Nov;49(11):106977. doi: 10.1016/j.ejso.2023.07.003. Epub 2023 Jul 4.

Abstract

Introduction: Retroperitoneal soft tissue sarcoma (RPS) is characterized by high recurrence rates. Since complete tumor resection, often necessitating multivisceral resection, enables long-term survival in both primary and recurrent disease, health related quality of life (QoL) after RPS resection has attracted increasing interest. However, data regarding this topic is limited. Here, we multidimensionally assessed long-term QoL after RPS resection.

Methods: Five previously validated (1. EORTC QLQ-C30, 2. WEMWBS, 3. FoP-Q-SF, 4. PC-PTSD, 5. Pro-CTCAE) were sent to patients having undergone resection of primary, recurrent and metastasized RPS at Heidelberg University Hospital between 10/2001 and 12/2020. Multivariable linear regression models were used to test associations between clinical/demographic variables and patient reported outcomes (PROs).

Results: Questionnaires were answered by 127 patients (71% response rate). The median interval between RPS diagnosis and assessment of PROs was 80 months. The overall Global Health score was 64.1 and comparable to the general German population. RPS patients reported deficits regarding emotional and social functioning, whereas physical limitations were less pronounced. Besides diarrhea, abdominal symptoms were comparable to the overall population. Tumor recurrences, the number of surgeries, multivisceral resections or postoperative complications did not significantly affect long-term QoL ratings.

Conclusion: RPS patients rate their QoL relatively high, even after multiple and multivisceral resections. Psychosocial well-being should be monitored in follow-up sessions to offer tailored support if necessary, thus improving postoperative care.

Keywords: Multivisceral resection; Patient reported outcome measures; Quality of life; Recurrence; Retroperitoneal soft tissue sarcoma.

MeSH terms

  • Humans
  • Neoplasm Recurrence, Local
  • Quality of Life
  • Retroperitoneal Neoplasms* / pathology
  • Retrospective Studies
  • Sarcoma* / pathology